The increasing prevalence of dental disorders, rising geriatric population, growing dental tourism in developing countries, and increasing disposable income are the major factors driving the growth of this market. On the other hand, stringent regulatory and clinical processes are expected to restrain market growth to a certain extent.

The growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market. On the other hand, the presence of stringent regulatory and clinical processes is one of the major factors restraining the market growth.

The global dental biomaterials market is projected to reach USD 9.6 billion by 2023 from USD 6.7 billion in 2018, at a CAGR of 7.4%.

Download PDF Brochure @

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198160556

The metallic biomaterials segment is expected to hold the largest share of the dental biomaterials market during the forecast period.

On the basis of type, the market is segmented into metallic, metal-ceramic, ceramic, polymeric, and natural dental biomaterials the metallic biomaterials segment accounted for the largest share in 2018. The large share of this segment can be attributed to the increasing penetration of Dental Implants and the wide applications of metallic biomaterials in dentistry.

Implantology applications to dominate the dental biomaterials market through the forecast period.

By application, the market is categorized into implantology, prosthodontics, orthodontics, and other applications. In 2018, the implantology application segment accounted for the largest share of the market.

The large share of this segment can be attributed to the increasing penetration of dental implants globally, high price and volume requirements of titanium used in manufacturing dental implants, rising incidence of dental diseases, increasing demand for cosmetic dentistry, growing dental tourism in emerging markets, and increasing disposable incomes in developing countries.

Dental implant and prosthetic manufacturers to hold the largest share of the dental biomaterial market during the forecast period.

Based on the end-user, the market is segmented into the dental implant and prosthetic manufacturers, dental laboratories, dental hospitals and clinics, and dental academies and research institutes. In 2018, the dental implant and prosthetic manufacturers segment accounted for the largest of the market.

The large share of this segment can be attributed to the increasing penetration of dental implants and prosthetics, growing adoption of CAD/CAM systems in dental clinics and laboratories, increasing number of dental practices, and the rising awareness on oral diseases.

Download Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=198160556

European is estimated to account for the largest share of the market during the forecast period.

Geographically, the global dental biomaterials industry is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2018, Europe held the largest share of this market, and this is primarily attributed to the growing geriatric population, increasing government expenditure on oral healthcare, higher adoption of the dental biomaterials to manufacture implants and other dental products, and a growing number of dental hospitals and clinics.

The global dental biomaterial market is consolidated at the top with the presence few big players in the market.

However, there are many local, regional, and global players operating in this market, making it highly competitive.

See Also: How Future will Impact Biomaterials Market in Healthcare and Biotechnology Industry?

Leading Companies in Dental Biomaterials Market

Straumann AG (Switzerland), Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), Dentsply Sirona, Inc. (US), 3M Company (US), Royal DSM (Netherlands), Carpenter Technology Corporation (US), Kuraray Co., Ltd (Japan), Medtronic Plc. (Ireland), Henry Schein, Inc. (US), Mitsui Chemicals, Inc. (Japan), Victrex Plc (UK), Ivoclar Vivadent AG (Principality of Liechtenstein), GC Corporation (Japan), Keystone Dental, Inc. (US), Datum Dental Ltd (Israel), BEGO Medical GmbH (Germany), and Cam Bioceramics B.V (Netherland) were the major players in this market. The companies are mainly focusing on acquisitions and agreements & collaborations to strengthen their market presence.

Geistlich Pharma AG (Switzerland) is a market leader in the dental bone graft substitute market. The company focuses on developing and manufacturing new products for regenerative medicine. Over the past three years, the company has adopted organic growth strategies, such as product development and launches and expansions to enhance its market presence.

For example, it recently improved its presence in Japan by launching the Bio-Gide (dental bone graft) in the market. In 2017, Geistlich also opened its tenth subsidiary, in India. This marked Geistlich’s entry into a potential emerging market for regenerative dentistry.

Zimmer Dental Inc. (US) stood second in the dental bone graft substitute market. The company is a provider of dental oral rehabilitation products and is a subsidiary of Zimmer Holdings, Inc. The company adopted expansions and acquisitions as key strategies for growth in the market over the last three years.

In 2015, Zimmer Holdings, Inc. acquired the company, Biomet Inc which helped it expand its dental biomaterials business. In 2017, Zimmer Biomet Holdings, Inc. reopened its dental division’s Zimmer Biomet Institute training center in Parsippany, New Jersey (US). This facility provides educational courses to dental clinicians around the world that are interested in restorative, surgical, and regenerative procedures.

Dentsply Sirona Inc. (US) is one of the leading providers of dental products. The company adopted acquisitions, new product launches, and agreements as its key growth strategies. For example, in February 2016, the company merged with DENTSPLY International Inc. This merger enabled the company in expanding its business and product offerings in the dental biomaterials market.

Download Sample Pages @ http://bit.ly/2BVV4p9

I consult businesses as a Corporate Communicator where I help companies about the growth of the healthcare market and solve their companies growth and research challenges through my creative marketing strategies. Reach out to me in case you have something I can help with.

Like this: Like Loading...